Basic neuroanatomy and neuropharmacology of cannabinoids

References

• Agarwal N, Pacher P, Tegeder I, Amaya F, Constantin CE, Brenner GJ, et al. Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors. Nature Neuroscience 2007; 10: 870–879
   PubMed Web of Science ®Google Scholar
• Ahluwalia J, Urban L, Capogna M, Bevan S, Nagy I. Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons. Neuroscience 2000; 100: 685–688
   PubMed Web of Science ®Google Scholar
• Ahn K, McKinney MK, Cravatt BF. Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. Chem Rev 2008; 108: 1687–1707
   PubMed Web of Science ®Google Scholar
• Akopian AN, Ruparel NB, Patwardhan A, Hargreaves KM. Cannabinoids desensitize capsaicin and mustard oil responses in sensory neurons via TRPA1 activation. Journal of Neuroscience 2008; 28: 1064–1075
   PubMed Web of Science ®Google Scholar
• Breivogel CS, Childers SR. The functional neuroanatomy of brain cannabinoid receptors. Neurobiology of Disease 1998; 5: 417–431
   PubMed Web of Science ®Google Scholar
• Breivogel CS, Griffin G, Di Marzo V, Martin BR. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Molecular Pharmacology 2001; 60: 155–163
   PubMed Web of Science ®Google Scholar
• Breivogel CS, Selley DE, Childers SR. Cannabinoid receptor agonist efficacy for stimulating [35S]GTPgammaS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity. Journal of Biological Chemistry 1998; 273: 16865–16873
   PubMed Web of Science ®Google Scholar
• Breivogel CS, Sim LJ, Childers SR. Regional differences in cannabinoid receptor/G-protein coupling in rat brain. Journal of Pharmacology and Experimental Therapeutics 1997; 282: 1632–1642
   PubMed Web of Science ®Google Scholar
• Breivogel CS, Walker JM, Huang SM, Roy MB, Childers SR. Cannabinoid signaling in rat cerebellar granule cells: G-protein activation, inhibition of glutamate release and endogenous cannabinoids. Neuropharmacology 2004; 47: 81–91
   PubMedGoogle Scholar
• Brusco A, Tagliaferro P, Saez T, Onaivi ES. Postsynaptic localization of CB2 cannabinoid receptors in the rat hippocampus. Synapse 2008; 62: 944–949
   PubMedGoogle Scholar
• Caterina MJ, Rosen TA, Tominaga M, Brake AJ, Julius D. A capsaicin-receptor homologue with a high threshold for noxious heat. Nature 1999; 398: 436–441
   PubMed Web of Science ®Google Scholar
• Chhatwal JP, Ressler KJ. Modulation of fear and anxiety by the endogenous cannabinoid system. CNS Spectrums 2007; 12: 211–220
   PubMed Web of Science ®Google Scholar
• Compton DR, Rice KC, DeCosta BR, Razdan RK, Melvin LS, Johnson MR, et al. Cannabinoid structure-activity relationships: Correlation of receptor binding and in vivo activities. Journal of Pharmacology and Experimental Therapeutics 1993; 265: 218–226
   PubMed Web of Science ®Google Scholar
• Cristino L, de Petrocellis L, Pryce G, Baker D, Guglielmotti V, Di Marzo V. Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain. Neuroscience 2006; 139: 1405–1415
   PubMed Web of Science ®Google Scholar
• Dean B, Sundram S, Bradbury R, Scarr E, Copolov D. Studies on [3H]CP-55940 binding in the human central nervous system: Regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use. Neuroscience 2001; 103: 9–15
   PubMed Web of Science ®Google Scholar
• DeSanty KP, Dar MS. Cannabinoid-induced motor incoordination through the cerebellar CB(1) receptor in mice. Pharmacology, Biochemistry and Behavior 2001; 69: 251–259
   PubMedGoogle Scholar
• Devane WA, Dysarz FA, 3rd, Johnson MR, Melvin LS, Howlett AC. Determination and characterization of a cannabinoid receptor in brain. Molecular Pharmacology 1998; 34: 605–613
   Google Scholar
• Di S, Malcher-Lopes R, Halmos KC, Tasker JG. Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: A fast feedback mechanism. Journal of Neuroscience 2003; 23: 4850–4857
   PubMed Web of Science ®Google Scholar
• Diana M, Melis M, Muntoni AL, Gessa GL. Mesolimbic dopaminergic decline after cannabinoid withdrawal. Proceedings of the National Academy of Science of the United States of America 1998; 95: 10269–10273
   PubMed Web of Science ®Google Scholar
• Egertova M, Cravatt BF, Elphick MR. Comparative analysis of fatty acid amide hydrolase and CB(1) cannabinoid receptor expression in the mouse brain: Evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling. Neuroscience 2003; 119: 481–496
   PubMedGoogle Scholar
• Egertova M, Elphick MR. Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of CB. Journal of Comparative Neurology 2000; 422: 159–171
   PubMed Web of Science ®Google Scholar
• Egertova M, Giang DK, Cravatt BF, Elphick MR. A new perspective on cannabinoid signalling: Complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain. Proceedings of the Royal Society B: Biological Sciences 1998; 265: 2081–2085
   PubMed Web of Science ®Google Scholar
• Eggan SM, Hashimoto T, Lewis DA. Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia. Archives of General Psychiatry 2008; 65: 772–784
   PubMed Web of Science ®Google Scholar
• Eggan SM, Lewis DA. Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: A regional and laminar analysis. Cerebral Cortex 2007; 17: 175–191
   PubMed Web of Science ®Google Scholar
• Farquhar-Smith WP, Egertova M, Bradbury EJ, McMahon SB, Rice AS, Elphick MR. Cannabinoid CB(1) receptor expression in rat spinal cord. Molecular and cellular neurosciences 2000; 15: 510–521
   PubMed Web of Science ®Google Scholar
• Fattore L, Spano MS, Altea S, Angius F, Fadda P, Fratta W. Cannabinoid self-administration in rats: Sex differences and the influence of ovarian function. British Journal of Pharmacology 2007; 152: 795–804
   PubMed Web of Science ®Google Scholar
• Fields HL, Heinricher MM, Mason P. Neurotransmitters in nociceptive modulatory circuits. Annual Review of Neuroscience 1991; 14: 219–245
   PubMed Web of Science ®Google Scholar
• Fitton AG, Pertwee RG. Changes in body temperature and oxygen consumption rate of conscious mice produced by intrahypothalamic and intracerebroventricular injections of delta 9-tetrahydrocannabinol. British Journal of Pharmacology 1982; 75: 409–414
   PubMedGoogle Scholar
• French ED. Delta9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors. Neuroscience Letters 1997; 226: 159–162
   PubMed Web of Science ®Google Scholar
• Fried PA, Smith AM. A literature review of the consequences of prenatal marihuana exposure. An emerging theme of a deficiency in aspects of executive function. Neurotoxicology and Teratology 2001; 23: 1–11
   PubMed Web of Science ®Google Scholar
• Gaoni Y, Mechoulam R. Isolation, structure, and partial synthesis of an active constituent of hashish. Journal of the American Chemical Society 1964; 86: 1646–1647
   Web of Science ®Google Scholar
• Gardner EL, Vorel SR. Cannabinoid transmission and reward-related events. Neurobiology of Disease 1998; 5: 502–533
   PubMed Web of Science ®Google Scholar
• Glass M, Dragunow M, Faull RLM. Cannabinoid receptors in the human brain: A detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 1997; 77: 299–318
   PubMed Web of Science ®Google Scholar
• Glass M, Felder CC. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: Evidence for a Gs linkage to the CB1 receptor. The Journal of Neuroscience 1997; 17: 5327–5333
   PubMed Web of Science ®Google Scholar
• Glass M, Northup JK. Agonist selective regulation of G proteins by cannabinoid CB(1) and CB(2) receptors. Molecular Pharmacology 1999; 56: 1362–1369
   PubMed Web of Science ®Google Scholar
• Gong JP, Onaivi ES, Ishiguro H, Liu QR, Tagliaferro PA, Brusco A, et al. Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain. Brain Research 2006; 1071: 10–23
   PubMed Web of Science ®Google Scholar
• Gulyas AI, Cravatt BF, Bracey MH, Dinh TP, Piomelli D, Boscia F, et al. Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. European Journal of Neuroscience 2004; 20: 441–458
   PubMed Web of Science ®Google Scholar
• Hagenacker T, Ledwig D, Busselberg D. Feedback mechanisms in the regulation of intracellular calcium ([Ca2+]i) in the peripheral nociceptive system: Role of TRPV-1 and pain related receptors. Cell Calcium 2008; 43: 215–227
   PubMed Web of Science ®Google Scholar
• Haney M, Ward AS, Comer SD, Foltin RW, Fischman MW. Abstinence symptoms following smoked marijuana in humans. Psychopharmacology 1999; 141: 395–404
   PubMed Web of Science ®Google Scholar
• Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC. Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. Journal of Neuroscience 1991; 11: 563–583
   PubMed Web of Science ®Google Scholar
• Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, et al. Cannabinoid receptor localization in brain. Proceedings of the National Academy of Sciences of the United States of America. 1990; 87: 1932–1936
   Google Scholar
• Hollister LE. Health aspects of cannabis. Pharmacological Reviews 1986; 38: 1–20
   PubMed Web of Science ®Google Scholar
• Howlett AC. Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compounds. Life Sciences 1984; 35: 1803–1810
   PubMed Web of Science ®Google Scholar
• Howlett AC, Breivogel CS, Childers SR, Deadwyler SA, Hampson RE, Porrino LJ. Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology 2004; 47(Suppl.1)345–358
   PubMed Web of Science ®Google Scholar
• Jansen EM, Haycock DA, Ward SJ, Seybold VS. Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles. Brain Research 1992; 575: 93–102
   PubMed Web of Science ®Google Scholar
• Jhaveri MD, Elmes SJ, Richardson D, Barrett DA, Kendall DA, Mason R, et al. Evidence for a novel functional role of cannabinoid CB(2) receptors in the thalamus of neuropathic rats. European Journal of Neuroscience 2008; 27: 1722–1730
   PubMedGoogle Scholar
• Jones RT, Benowitz NL, Herning RI. Clinical relevance of cannabis tolerance and dependence. Journal of Clinical Pharmacology 1981; 21: 143S–152S
   PubMed Web of Science ®Google Scholar
• Jonsson KO, Holt S, Fowler CJ. The endocannabinoid system: Current pharmacological research and therapeutic possibilities. Basic & Clinical Pharmacology & Toxicology 2006; 98: 124–134
   PubMed Web of Science ®Google Scholar
• Katona I, Rancz EA, Acsady L, Ledent C, Mackie K, Hajos N, et al. Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. Journal of Neuroscience 2001; 21: 9506–9518
   PubMed Web of Science ®Google Scholar
• Katona I, Urban GM, Wallace M, Ledent C, Jung KM, Piomelli D, et al. Molecular composition of the endocannabinoid system at glutamatergic synapses. Journal of Neuroscience 2006; 26: 5628–5637
   PubMedGoogle Scholar
• Kearn CS, Blake-Palmer K, Daniel E, Mackie K, Glass M. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: A mechanism for receptor cross-talk?. Molecular Pharmacology 2005; 67: 1697–1704
   PubMed Web of Science ®Google Scholar
• Kim D, Cavanaugh EJ, Simkin D. Inhibition of transient receptor potential A1 channel by phosphatidylinositol-4,5-bisphosphate. American Journal of Physiology – Cell Physiology 2008; 295: C92–99
   PubMed Web of Science ®Google Scholar
• Koethe D, Llenos IC, Dulay JR, Hoyer C, Torrey EF, Leweke FM, et al. Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression. Journal of Neural Transmission 2007; 114: 1055–1063
   PubMed Web of Science ®Google Scholar
• Kogan NM, Mechoulam R. Cannabinoids in health and disease. Dialogues in Clinical Neuroscience 2007; 9: 413–430
   PubMedGoogle Scholar
• Kowase T, Nakazato Y, Yoko OH, Morikawa A, Kojima I. Immunohistochemical localization of growth factor-regulated channel (GRC) in human tissues. Endocrine Journal 2002; 49: 349–355
   PubMedGoogle Scholar
• Kreitzer AC, Regehr WG. Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron 2001; 29: 717–727
   PubMed Web of Science ®Google Scholar
• Lauckner JE, Jensen JB, Chen HY, Lu HC, Hille B, Mackie K. GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. Proceedings of the National Academy of Sciences USA. 2008; 105: 2699–2704
   Google Scholar
• Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, Beslot F, et al. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 1999; 283: 401–404
   PubMed Web of Science ®Google Scholar
• Lichtman AH, Martin BR. Spinal and supraspinal components of cannabinoid-induced antinociception. Journal of Pharmacology and Experimental Therapeutics 1991; 258: 517–523
   PubMed Web of Science ®Google Scholar
• Lidow MS, Williams GV, Goldman-Rakic PS. The cerebral cortex: A case for a common site of action of antipsychotics. Trends in Pharmacological Sciences 1998; 19: 136–140
   PubMedGoogle Scholar
• Lupica CR, Riegel AC, Hoffman AF. Marijuana and cannabinoid regulation of brain reward circuits. British Journal of Pharmacology 2004; 143: 227–234
   PubMed Web of Science ®Google Scholar
• Maccarrone M, Rossi S, Bari M, De Chiara V, Fezza F, Musella A, et al. Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum. Nature Neuroscience 2008; 11: 152–159
   PubMed Web of Science ®Google Scholar
• Mackie K. Cannabinoid receptor homo- and heterodimerization. Life Sciences 2005; 77: 1667–1673
   PubMed Web of Science ®Google Scholar
• Marsicano G, Lutz B. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. European Journal of Neuroscience 1999; 11: 4213–4225
   PubMed Web of Science ®Google Scholar
• Martin WJ, Hohmann AG, Walker JM. Suppression of noxious stimulus-evoked activity in the ventral posterolateral nucleus of the thalamus by a cannabinoid agonist: Correlation between electrophysiological and antinociceptive effects. Journal of Neuroscience 1996; 16: 6601–6611
   PubMed Web of Science ®Google Scholar
• Martin WJ, Patrick SL, Coffin PO, Tsou K, Walker JM. An examination of the central sites of action of cannabinoid-induced antinociception in the rat. Life Sciences 1995; 56: 2103–2109
   PubMed Web of Science ®Google Scholar
• Martin WJ, Tsou K, Walker JM. Cannabinoid receptor-mediated inhibition of the rat tail-flick reflex after microinjection into the rostral ventromedial medulla. Neuroscience Letters 1998; 242: 33–36
   PubMed Web of Science ®Google Scholar
• Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990; 346: 561–564
   PubMed Web of Science ®Google Scholar
• Melis M, Pistis M, Perra S, Muntoni AL, Pillolla G, Gessa GL. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. Journal of Neuroscience 2004; 24: 53–62
   PubMed Web of Science ®Google Scholar
• Meng ID, Manning BH, Martin WJ, Fields HL. An analgesia circuit activated by cannabinoids. Nature 1998; 395: 381–383
   PubMed Web of Science ®Google Scholar
• Michalik L, Auwerx J, Berger JP, Chatterjee VK, Glass CK, Gonzalez FJ, et al. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacological Reviews 2006; 58: 726–741
   PubMed Web of Science ®Google Scholar
• Monory K, Blaudzun H, Massa F, Kaiser N, Lemberger T, Schutz G, et al. Genetic dissection of behavioural and autonomic effects of Delta(9)-tetrahydrocannabinol in mice. PLoS Biol 2007; 5: 2354–2368
   Google Scholar
• Morgan CJ, Curran HV. Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis. British Journal of Psychiatry 2008; 192: 306–307
   PubMed Web of Science ®Google Scholar
• Movahed P, Jonsson BA, Birnir B, Wingstrand JA, Jorgensen TD, Ermund A, et al. Endogenous unsaturated C18 N-acylethanolamines are vanilloid receptor (TRPV1) agonists. Journal of Biological Chemistry 2005; 280: 38496–38504
   PubMed Web of Science ®Google Scholar
• Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993; 365: 61–65
   PubMed Web of Science ®Google Scholar
• Navarrete M, Araque A. Endocannabinoids mediate neuron-astrocyte communication. Neuron 2008; 57: 883–893
   PubMed Web of Science ®Google Scholar
• Newell KA, Deng C, Huang XF. Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia. Experimental Brain Research 2006; 172: 556–560
   PubMed Web of Science ®Google Scholar
• O'Sullivan SE. Cannabinoids go nuclear: Evidence for activation of peroxisome proliferator-activated receptors. British Journal of Pharmacology 2007; 152: 576–582
   PubMed Web of Science ®Google Scholar
• Onaivi ES, Ishiguro H, Gong JP, Patel S, Perchuk A, Meozzi PA, et al. Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Annals of the New York Academy of Sciences 2006; 1074: 514–536
   PubMed Web of Science ®Google Scholar
• Ong WY, Mackie K. A light and electron microscopic study of the CB1 cannabinoid receptor in primate brain. Neuroscience 1999; 92: 1177–1191
   PubMedGoogle Scholar
• Patel S, Hillard CJ. Cannabinoid CB(1) receptor agonists produce cerebellar dysfunction in mice. Journal of Pharmacology and Experimental Therapeutics 2001; 297: 629–637
   PubMed Web of Science ®Google Scholar
• Pertwee RG, Wickens AP. Enhancement by chlordiazepoxide of catalepsy induced in rats by intravenous or intrapallidal injections of enantiomeric cannabinoids. Neuropharmacology 1991; 30: 237–244
   PubMed Web of Science ®Google Scholar
• Pickel VM, Chan J, Kash TL, Rodriguez JJ, MacKie K. Compartment-specific localization of cannabinoid 1 (CB1) and mu-opioid receptors in rat nucleus accumbens. Neuroscience 2004; 127: 101–112
   PubMedGoogle Scholar
• Pickel VM, Chan J, Kearn CS, Mackie K. Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbens. Journal of Comparative Neurology 2006; 495: 299–313
   PubMedGoogle Scholar
• Piomelli D. The molecular logic of endocannabinoid signalling. Nature Reviews Pharmacology 2003; 4: 873–884
   PubMed Web of Science ®Google Scholar
• Prather PL, Martin NA, Breivogel CS, Childers SR. Activation of cannabinoid receptors in rat brain by WIN 55212-2 produces coupling to multiple G protein alpha-subunits with different potencies. Molecular Pharmacology 2000; 57: 1000–1010
   PubMed Web of Science ®Google Scholar
• Qin N, Neeper MP, Liu Y, Hutchinson TL, Lubin ML, Flores CM. TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons. Journal of Neuroscience 2008; 28: 6231–6238
   PubMed Web of Science ®Google Scholar
• Rawls SM, Cabassa J, Geller EB, Adler MW. CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [(4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one]-induced hypothermia. Journal of Pharmacology and Experimental Therapeutics 2002; 301: 963–968
   PubMedGoogle Scholar
• Rios C, Gomes I, Devi LA. Mu opioid and CB1 cannabinoid receptor interactions: Reciprocal inhibition of receptor signaling and neuritogenesis. British Journal of Pharmacology 2006; 148: 387–395
   PubMed Web of Science ®Google Scholar
• Romero J, Hillard CJ, Calero M, Rabano A. Fatty acid amide hydrolase localization in the human central nervous system: An immunohistochemical study. Molecular Brain Research 2002; 100: 85–93
   PubMedGoogle Scholar
• Ryberg E, Larsson N, Sjogren S, Hjorth S, Hermansson NO, Leonova J, et al. The orphan receptor GPR55 is a novel cannabinoid receptor. British Journal of Pharmacology 2007; 152: 1092–1101
   PubMed Web of Science ®Google Scholar
• Sagar DR, Kelly S, Millns PJ, O'Shaughnessey CT, Kendall DA, Chapman V. Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats. European Journal of Neuroscience 2005; 22: 371–379
   PubMed Web of Science ®Google Scholar
• Salio C, Doly S, Fischer J, Franzoni MF, Conrath M. Neuronal and astrocytic localization of the cannabinoid receptor-1 in the dorsal horn of the rat spinal cord. Neuroscience Letters 2002; 329: 13–16
   PubMed Web of Science ®Google Scholar
• Sawzdargo M, Nguyen T, Lee DK, Lynch KR, Cheng R, Heng HH, et al. Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain. Molecular Brain Research 1999; 62: 193–198
   Google Scholar
• Sim-Selley LJ. Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids. Critical Reviews in Neurobiology 2003; 15: 91–119
   PubMedGoogle Scholar
• Sim-Selley LJ, Vogt LJ, Vogt BA, Childers SR. Cellular localization of cannabinoid receptors and activated G-proteins in rat anterior cingulate cortex. Life Sciences 2002; 71: 2217–2226
   PubMed Web of Science ®Google Scholar
• Sim LJ, Hampson RE, Deadwyler SA, Childers SR. Effects of chronic treatment with D9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgS autoradiography in rat brain. Journal of Neuroscience 1996; 16: 8057–8066
   PubMed Web of Science ®Google Scholar
• Sim LJ, Selley DE, Childers SR. In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5′-[gamma-[35S]thio]-triphosphate binding. Proceedings of the National Academy of Sciences of the United States of America 1995; 92: 7242–7246
   PubMed Web of Science ®Google Scholar
• Simon GM, Cravatt BF. Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-N-acyl ethanolamine precursors in mouse brain. J Biol Chem 2008; 283: 9341–9349
   PubMed Web of Science ®Google Scholar
• Sun Y, Alexander SP, Garle MJ, Gibson CL, Hewitt K, Murphy SP, et al. Cannabinoid activation of PPAR alpha; A novel neuroprotective mechanism. British Journal of Pharmacology 2007; 152: 734–743
   PubMed Web of Science ®Google Scholar
• Svizenska I, Dubovy P, Sulcova A. Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures – A short review. Pharmacology, Biochemistry and Behavior 2008; 90: 501–511
   PubMed Web of Science ®Google Scholar
• Tanda G, Loddo P, Di Chiara G. Dependence of mesolimbic dopamine transmission on delta9-tetrahydrocannabinol. European Journal of Pharmacology 1999; 376: 23–26
   PubMed Web of Science ®Google Scholar
• Tsou K, Brown S, Sanudo-Pena MC, Mackie K, Walker JM. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 1998; 83: 393–411
   PubMed Web of Science ®Google Scholar
• Van Sickle MD, Duncan M, Kingsley PJ, Mouihate A, Urbani P, Mackie K, et al. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 2005; 310: 329–332
   PubMed Web of Science ®Google Scholar
• Villares J. Chronic use of marijuana decreases cannabinoid receptor binding and mRNA expression in the human brain. Neuroscience 2007; 145: 323–334
   PubMed Web of Science ®Google Scholar
• Wager-Miller J, Westenbroek R, Mackie K. Dimerization of G protein-coupled receptors: CB1 cannabinoid receptors as an example. Chemistry and Physics of Lipids 2002; 121: 83–89
   PubMedGoogle Scholar
• Walter L, Franklin A, Witting A, Moller T, Stella N. Astrocytes in culture produce anandamide and other acylethanolamides. Journal of Biological Chemistry 2002; 277: 20869–20876
   PubMedGoogle Scholar
• Wang X, Dow-Edwards D, Keller E, Hurd YL. Preferential limbic expression of the cannabinoid receptor mRNA in the human fetal brain. Neuroscience 2003; 118: 681–694
   PubMed Web of Science ®Google Scholar
• Wiley JL, Kendler SH, Burston JJ, Howard DR, Selley DE, Sim-Selley LJ. Antipsychotic-induced alterations in CB(1) receptor-mediated G-protein signaling and in vivo pharmacology in rats. Neuropharmacology 2008; 55: 1183–1190
   PubMedGoogle Scholar
• Wilson RI, Nicoll RA. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 2001; 410: 588–592
   PubMed Web of Science ®Google Scholar
• Wright S. Cannabinoid-based medicines for neurological disorders – Clinical evidence. Molecular neurobiology 2007; 36: 129–136
   PubMedGoogle Scholar
• Yoshida T, Fukaya M, Uchigashima M, Miura E, Kamiya H, Kano M, et al. Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor. Journal of Neuroscience 2006; 26: 4740–4751
   PubMed Web of Science ®Google Scholar
• Zangen A, Solinas M, Ikemoto S, Goldberg SR, Wise RA. Two brain sites for cannabinoid reward. The Journal of Neuroscience 2006; 26: 4901–4907
   PubMed Web of Science ®Google Scholar
• Zavitsanou K, Garrick T, Huang XF. Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2004; 28: 355–360
   PubMed Web of Science ®Google Scholar
• Zimmer A, Zimmer AM, Hohmann AG, Herkenham M, Bonner TI. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proceedings of the National Academy of Sciences of the United States of America. 1999; 96: 5780–5785
   Google Scholar